JOHNSON & JOHNSON |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137 EUR | +0.13% |
|
-1.37% | -3.35% |
| 28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 82TCr | ||||||
| 64TCr | ||||||
| 31TCr | ||||||
| 30TCr | ||||||
| 24TCr |
